Shopping Cart
Remove All
Your shopping cart is currently empty
Cholesterol24-hydroxylase-IN-3 is an orally bioavailable, selective, brain-penetrant CH24H inhibitor (IC50 = 23 nM), classified as a 1,3-oxazole derivative. It inhibits CH24H enzyme activity competitively by coordinating the 1,3-oxazole nitrogen atom with the heme iron, with the cyclopropyl group occupying a hydrophobic pocket. Cholesterol24-hydroxylase-IN-3 has potential applications in research on neurological disorders like epilepsy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Cholesterol24-hydroxylase-IN-3 is an orally bioavailable, selective, brain-penetrant CH24H inhibitor (IC50 = 23 nM), classified as a 1,3-oxazole derivative. It inhibits CH24H enzyme activity competitively by coordinating the 1,3-oxazole nitrogen atom with the heme iron, with the cyclopropyl group occupying a hydrophobic pocket. Cholesterol24-hydroxylase-IN-3 has potential applications in research on neurological disorders like epilepsy. |
| In vitro | Cholesterol 24-hydroxylase-IN-3 (Compound 4L) (10 μM, 1 h) selectively inhibits CH24H while exhibiting minimal inhibition of other CYP enzymes, with inhibition rates of 7.3% for CYP3A4, 10% for CYP2C8, 8.5% for CYP2C9, and 49% for CYP2D6. |
| In vivo | Cholesterol 24-hydroxylase-IN-3 (Compound 4L) at a dose of 30 mg/kg (i.g, single dose) effectively crosses the blood-brain barrier in mice and reduces levels of 24S-hydroxycholesterol (24HC) in the brain, offering a novel therapeutic approach for neurological disorders. |
| Molecular Weight | 297.23 |
| Formula | C13H10F3N3O2 |
| Cas No. | 1630746-27-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.